Great news! Definitely moving in the right direction. Still pending IND approval with the FDA per the article. But I’m curious if the FDA considers trials conducted in other countries in their data when approving new drugs. Because the article also mentioned they were conducting trials in the US.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.